plaining why the two drug classes might have different clinical effects. In addition, rapid functional plasticity of GABA, receptors has been demonstrated to occur during status epilepticus in rats. During status epilepticus, there was a substantial reduction of diazepam potency for termination of the seizures. The loss of sensitivity of the animals to diazepam during status epilepticus was accompanied by an alteration in the functional properties of hippocampal dentate granule cell GABA, receptors. Dentate granule cell GABA, receptor currents from rats undergoing status epilepticus had reduced sensitivity to diazepam and zinc but normal sensitivity to GABA and pentobarbital. Therefore, the prolonged seizures of status epilepticus rapidly altered the functional properties of hippocampal dentate granule cell GABA, receptors, possibly explaining why benzodiazepines and barbiturates may not be equally effective during treatment of the prolonged seizures of status epilepticus. A comprehensive understanding of the cellular and molecular events leading to the development, maintenance, and cytotoxicity of status epilepticus should permit development of more effective treatment strategies and reduction in the mortality and morbidity of status epilepticus. Key Words: GABAHippocampus-Seizures-Status epilepticus.
Most seizures are relatively brief and self-terminating. During some seizures, however, early termination fails and status epilepticus ensues. One hypothesis for development of status epilepticus is that activation of y-aminobutyric acid (GABA) receptor-mediated inhibition is responsible for normal termination of a seizure. If the GABAergic inhibition fails to terminate the seizure, a progressive reduction in GABA, receptor-mediated inhibition develops which, when severe enough, results in a prolonged self-sustained seizure (1, 2) . There is experimental support for this hypothesis. Prolonged hippocampal seizures reduce GABA, receptor-mediated inhibi-pl-2), and all of the sequences within each subunit family are homologous, with about 70-80% amino acid sequence identity (Table 1) . Additional diversity arises from RNA splice variants, described thus far for y2 (8) and p4 (9,lO) . Each GABA, receptor-subunit cDNA encodes for a polypeptide of about 50 kDa, with putative N-glycosylation sites and four a-helical, hydrophobic membrane-spanning regions (5, 6) . Between the third and fourth membrane-spanning regions is a putative hydrophilic cytoplasmic region of highly variable sequence involved in intracellular regulatory mechanisms such as phosphorylation.
The current understanding of the molecular structure of the GABA,-receptor-ion channel complex is that it is a heteropentameric glycoprotein of about 275 kDa, composed of combinations of multiple polypeptide subunits. The subunits form a quasi-symmetric structure around the ion channel, with each subunit contributing to the wall of the channel (6) . The model is based on the nicotinic acetylcholine receptor, another member of the ligand-gated ion channel gene superfamily, and electron microscopic image analysis of the native GABA, receptors (1 1) . However, the number of each subtype and their stoichiometry remain uncertain. GABA, receptors are generally believed to be composed of combinations of a-, p-, y-, 6-and possibly €-subunits. The p-subunit forms homopentameric GABA, receptors in the retina; the role of the rr-subunit remains uncertain. 
Pharmacology of recombinant GABAA receptors
The pharmacologic properties of GABA, receptors are dependent on subunit subtype composition. The benzodiazepine sensitivity of GABA, receptors differs when different a subtypes are combined with p-and y-subunits (Table 2) (12) (13) (14) (15) (16) . The alpy-subunits produce diazepam-and zolpidem-sensitive BZ 1 GABA, receptors, a 2 p y -and a3py-subunits produce BZ2a,b GABA, receptors with high diazepam and low zolpidem sensitivity, &Spy-subunits produce BZ2c GABA, receptors with high diazepam sensitivity but zolpidem insensitivity, and 014-or a6py-subunits produce BZ3 GABA, receptors that are benzodiazepine insensitive. Barbiturates bind to an allosteric regulatory site on the GABA, receptor, but the subunit location of the barbiturate binding site is unknown.
There is growing evidence for the structural diversity of native GABA, receptors derived from whole brain. The distribution of mRNAs in the CNS determined by in situ hybridization is very different for each subunit subtype. For example, the p-subunit is expressed primarily in the retina (17) , whereas various a, p, and y subtypes and the single 6 subtype show very different regional as well as developmental distributions (1 [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Immunoprecipitation studies have shown that different specific combinations of GABA, receptor-subtypes occur in the different regions of the brain. McKernan et al. (21) found that a majority of native GABAA receptors contain only a single a-subtype and that a l -, 012-, a3-, or 1x5-subtypes exist in combination with a p-and a y2-subtype. Serum specific for the 6 subunit was found to precipitate a specific set of GABA, receptors that contained a l , a3 p2/3y2 subtypes but not the a5 subtype (22) . Partial colocalization suggests some tentative major oligomeric assemblies, e.g., Wisden et al. (19) propose the likely existence of at least five combinations: (a) alp2y2; (b) a2p3yx; (c) a 5 p l y x ; (d) ala4P26; and (e) aIa6p26. They also note that the yl-subunit is limited to the limbic regions of amygdala, hypothalamus, and septum.
Hippocampal GABAA receptors
It is likely that multiple specific GABA, receptor isoforms are expressed in the hippocampus. The existence of GABA, receptor isoforms has been demonstrated by in vivo and in vitro pharmacologic studies. Immunopurification and in situ hybridization studies have shown that the subtypes display a heterogeneous distribution in the CNS. Experiments using subunit-specific antibodies for quantitative immunopurification of GABA, receptors from specific regions of the CNS and comparison of the identified subunit combinations with the localization of the corresponding mRNA have allowed initial identification of the subunit composition of some GABA, receptor isoforms. Hippocampal dentate granule cells can potentially express GABA, receptors with distinct munopurification study using a 6-specific antibody has been reported, demonstrating that the &subunit is associated with the a l -, a3-, p2/3-, and y2 subtypes. This study provided no information regarding expression of a3-, a4-, PI-, or yl-subtypes by granule cells. Immunoprecipitation studies did not reveal if subtype combinations precipitated from brains were functionally expressed by granule cells. Finally, these studies did not determine if more than one GABA, receptor isoform was expressed by single granule cell (22) .
Pharmacology of dentate granule cell GABA, receptors
The pharmacologic properties of GABA, receptor currents recorded from acutely dissociated hippocampal dentate granule cells from 28-to 35-day-old rats were characterized using the whole-cell patch-clamp technique (23) . Granule cells were voltage-clamped to 0 mV and GABA was applied using a modified U-tube rapid application technique.
Concentration-dependent GABA, receptor currents were obtained from individual granule cells (Fig. 1A) . Mean GABA EC,, was 46 & 10 pM, maximal current was 842 f 54 CpA, and the Hill slope was 1.2 ( Fig. 1C) . Diazepam-enhanced granule cell GABAA receptor currents were evoked by 10 p,M GABA in a concentrationdependent fashion ( Fig. 2A,B (Fig. 2C) . Zn++ reduced granule cell GABA, receptor currents evoked by 30 pM GABA in a concentration-dependent fashion (Fig. 3A,B) . Mean IC,, was 28.5 f 11 pM, maximal inhibition was 77 ? 3%, and the Hill slope was 2.0 2 0.4 ( Fig. 3C ).
INVOLVEMENT OF HIPPOCAMPAL GABA, RECEPTORS IN DEVELOPMENT OF STATUS EPILEPTICUS

Hippocampal involvement in status epilepticus
Several lines of evidence suggest that the hippocampal-parahippocampal loop can sustain seizures during status epilepticus. In functional mapping studies combining EEG and 2-deoxyglucose mapping of metabolic activity during status epilepticus, increased glucose utilization occurred in hippocampal-parahippocampal structures (subiculum, parasubiculum, and entorhinal cortex), limbic structures, including the amygdala, and extralimbic structures (24) . Similarly, GABA, receptorcombined hippocampal-parahippocampal slices sustain status epilepticus. Therefore, it is important to understand the functional properties of hippocampal GABAA receptors and how they are modified by status epilepti-
Whole-animal studies of acute changes in the pharmacology of status epilepticus
Status epilepticus was induced in Sprague-Dawley rats by intraperitoneal injection of 3 mEqkg LiCl, followed 20 h later by 50 mgkg pilocarpine (25) . After pilocarpine injection, the rats were observed continuously for occurrence of behavioral seizures. The time to onset of behavioral seizures was recorded and the seizures were observed. Behavioral seizures evoked by lithiudpilocarpine were characterized by immobility, repetitive chewing, head nodding, vibrissial twitching, forelimb clonus with or without rearing, and falling (26, 27) . Seizure termination was defined as the absence of forelimb clonus or falling, facial twitching, and stop and stare activity. In addition, resumption of normal behavior within 30 min of drug injection was assessed. seizures within 5 rnin of diazepam injection was plotted against log diazepam dose. The data were fitted to a sigmoidal dose-response curve, with the maximum fixed to 100% and minimum to 0%. The ED,,s were derived from the equation that best fitted the data. Behavioral seizures began 3-5 min after injection with pilocarpine. A detailed diazepam dose-response analysis was performed using a total of 30 rats. After 10 rnin of seizures, increasing doses of diazepam from 2 mgkg to 20 mgkg were administered to four groups of rats: 2 mgkg, n = 5; 7.5 mgkg, n = 3; 10 mgkg, n = 3; and 20 mgkg, n = 3. After 45 min of seizures, three rats were treated with 20 mgkg, 30 mgkg, 50 mgkg, and 100 mgkg of diazepam. Four rats were not treated with an AED and these rats continued to have seizures for 2 h. After 10 min of seizures, diazepam (20 mgkg) terminated seizures in all treated animals (n = 3). However, after 45 rnin of seizures (status epilepticus), diazepam (20 mgkg) terminated the seizures in none of the animals (n = 3). At high doses of diazepam (50 mgkg and 100 mgkg), behavioral seizures appeared terminated, but rats were extremely sedated and resumption of normal activity did not occur. The dose-response data were fitted to a sigmoidal dose-response curve and the ED,,s for diazepam control of behavioral seizures after 10 min and 45 min of seizures were derived (Fig. 4) . The doseresponse curve showed that the ED,, for diazepaminduced termination of seizures shifted from 4.2 mgkg when administered after 10 min of continuous seizures to 40 mgkg when administered after 45 min of continuous seizures.
Because diazepam exerts its anticonvulsant effect primarily by enhancing GABAergic inhibition by acting on GABA, receptors (28), we hypothesized that seizures altered the functional properties of GABA, receptors. The seizures could potentially alter the modulation of GABA, receptor by various drugs, such as enhancement by benzodiazepines, barbiturates, and neurosteroids and antagonism by penicillin, picrotoxin, bicuculline, and Zn++. We characterized GABAA receptor currents recorded from acutely isolated hippocampal dentate granule cells, their potentiation by benzodiazepines and barbiturates, and their inhibition by Zn++.
Regulation of dentate granule cell GABA, receptor currents from rats undergoing status epilepticus
GABA, receptor currents were reduced in granule cells from rats undergoing status epilepticus
Whole-cell voltage-clamp recordings were made from dentate granule cells (29, 30) acutely isolated from con- trol rats or from same-age rats that experienced 45 min of continuous seizures (status epilepticus) (1) . When access was initially established in granule cells from control rats, 10 FM GABA, receptor currents increased slightly and became stable in 2-4 min (run-up) (Fig. 5A) . The stable response compared with the first response increased by 174 ? 47% (n = 4). In contrast, GABA, receptor currents evoked from granule cells from animals undergoing status epilepticus required 10 min to stabilize, and the run-up was substantially larger (374 2 66%; n = 5, p < 0.05; Fig. 5B ). Once stable responses to 10 pM GABA were obtained, GABA was applied to granule cells at concentrations ranging from 1 to 1,000 pM (Fig. 6 ). For each of the groups, data from individual cells were pooled and fitted to a sigmoidal logistic equation. In neurons from control animals, the mean GABA EC,, for GABAA receptors was 42 & 19 pM (n = 17), similar to that of neurons from animals undergoing status epilepticus: 33 & 14 pM; n = 9; (p > 0.05). The maximal GABA, receptor current in cells from control animals was 962 k 109 pA (n = 19), similar to that of cells from animals undergoing status epilepticus: 820 k 188 pA ( n = 9). Thus, after status epilepticus there was increased run-up of GABA, receptor currents after initial access, but once stable currents had been obtained, the potency and efficacy of GABA on dentate granule cell GABA, receptors were similar to those in neurons from control animals. Modulation of GABA, receptor currents was studied in dentate granule cells isolated from control rats or from those undergoing status epilepticus after stabilization of currents.
HIPPOCAMPAL ALTERATIONS IN SE
Diazepam enhancement of GABA, receptor currents was diminished in granule cells from rats undergoing status epilepticus
In hippocampal dentate granule cells from control animals, 10 pM GABA administered with 300 nM diazepam enhanced GABA, receptor currents in all neurons by 68 k 10% (n = 6) (Fig. 7A) . In contrast, in dentate granule cells from animals undergoing status epilepticus, 300 nM diazepam inconsistently enhanced 6 or 10 pM GABA-evoked GABA, receptor currents by 10 & 6%; (n = 5; p < 0.001, grouped t test) (Fig. 7B) . In neurons from control animals, 1 pM diazepam enhanced GABA, receptor currents by 92 f 6% (n = 6), but in neurons from animals undergoing status epilepticus, 3 pM diazepam enhanced GABA, receptor currents by 5 1 f 8% (n = 5 ; p < 0.05, grouped t test) (Fig. 7) . The EC,, for diazepam enhancement of GABA, receptor currents in neurons from control animals was 195 & 12 nM, and the EC,, in neurons from animals undergoing status epilepticus was 4.4 & 0.25 pM (Fig. 8) . Therefore, the prolonged seizures of status epilepticus reduced the potency and efficacy of diazepam for enhancement of granule cell GABA, receptor currents.
Zinc inhibition of GABA, receptor currents was diminished in granule cells from rats undergoing status epilepticus
Because Zn++ modulation of recombinant GABAA receptor currents varies inversely with benzodiazepine sensitivity (32, 33) , Zn++ inhibition of granule cell GABA, receptor currents was studied. Zn++ was less potent in inhibiting GABA, receptor currents recorded from granule cells isolated from animals undergoing status epilepticus than from control granule cells. In neurons from control animals, GABA, receptor currents were inhibited 59 & 4% ( n = 8) by 100 pM Zn++ (Fig. 9A ), but in neurons isolated from animals undergoing status epilepticus the inhibition was reduced to 39 5 6% (n = 6; p < 0.05, grouped t test) (Fig. 9B) . In dentate granule cells from control rats, GABA, receptor currents were reduced by Zn++ in a concentration-dependent fashion with an IC,, of 30 & 3.6 pM (n = 12) (Fig. 10) . In dentate granule cells isolated from animals undergoing status epilepticus, the IC,, of Zn++ inhibition of GABA, receptor currents was 123 f 15 pM ( n = 10, p < 0.01, grouped t test) (Fig. 10) . The maximal inhibition of GABA, receptor currents by Zn++ was unchanged (78 f 3% in neurons from control animals and 90 & 16% in neurons from animals undergoing status epilepticus). Therefore, the prolonged seizures of status epilepticus reduced the potency of Zn++ without altering the efficacy of inhibition of granule cell GABA, receptor currents.
Pentobarbital enhancement of GABA, receptor currents was unchanged in cells from rats undergoing status epilepticus
In neurons from control animals ( n = 6), GABA, receptor currents elicited by 10 pM GABA were enhanced 77 & 7% by 30 pM pentobarbital (Fig. llA) , whereas in neurons from animals undergoing status epilepticus (n = 3), GABAA receptor currents elicited by 10 pM GABA were enhanced 62 & 11% by 30 p,M pentobarbital ( P > 0.05, grouped t test) (Fig. 11B) longed seizures of status epilepticus did not alter the efficacy or potency of pentobarbital enhancement of GABA, receptor currents in dentate granule cells.
DISCUSSION
Diazepam loses effectiveness in the treatment of status epilepticus
This study demonstrates the prolonged seizures of status epilepticus reduce the ability of diazepam to terminate status epilepticus. The refractoriness to diazepam results from loss of the potency but not the efficacy of diazepam. Refractoriness to diazepam has been previously reported in both humans (34) and rats (27) . Several possible mechanisms can be hypothesized to explain the loss of diazepam effectiveness in the treatment of the prolonged seizures of status epilepticus: seizures may become more intense; there may be enhanced excitatory transmission; or there may be altered inhibition. Past studies indicate the hippocampus is involved in the generation of status epilepticus (2, 35, 36) and that hippocampal GABAergic inhibition is altered during status epilepticus (3, 37, 38) . These studies suggest that refractoriness of seizures to diazepam might result from altered GABA, receptor function in the hippocampus. The experiments reported here support this hypothesis.
Plasticity of GABA, receptor function during status epilepticus
During status epilepticus, GABA, receptor-mediated inhibition in the hippocampus is reduced in both the CA 1 + 300 nM Diazepam region and the dentate gyms (3, 38, 39) . One proposed mechanism for the reduction in inhibition is a specific alteration in the functional properties of GABA, receptors (38) . We have demonstrated that two functional properties of GABA, receptors, diazepam enhancement and Znf+ inhibition of GABA, receptor currents, were altered by the prolonged seizures (1). This plasticity of GABA, receptors in the hippocampus may play a role in the pathogenesis and treatment of status epilepticus. Seizures in the hippocampus reduce GABAergic inhibition, and the findings presented here demonstrate that this is due in part to changes in GABA, receptor function. The reduction in diazepam sensitivity of dentate granule cell GABA, receptors parallels the loss of effectiveness of diazepam in the treatment of experimental status epilepticus. It is possible that changes in the diazepam sensitivity of dentate granule cell GABA, receptors reflect reduction of diazepam sensitivity in the treatment of status epilepticus. In addition, pentobarbital sensitivity of GABA, receptors on dentate granule cells isolated from animals undergoing status epilepticus was preserved. This suggested that status epilepticus alters specific properties of GABA, receptors rather than causing a generalized dysfunction of the receptor. comparable to the current study. However, brief seizures of temporal lobe epilepsy and prolonged seizures of status epilepticus are distinct phenomena. Almost 50% of patients who experience an episode of status epilepticus have not previously had a seizure (40) . Epileptic seizures are brief, and data from epilepsy monitoring units indicate that the majority of seizures spontaneously terminate within 10 min (41). In contrast, status epilepticus is a syndrome consisting of a very prolonged seizure with continuous evolution of neurologic state, worsening cerebral metabolism, a steady rise in core temperature, a rise in blood pressure, lactic acidosis, hyperglycemia (42) , and increased catecholamine levels (43) . Hippocampal injury and neuronal loss occur as a result of status epilepticus in humans (44, 45) and in most animal models of status epilepticus (46) (47) (48) (49) (50) . However, whether individual brief seizures cause neuronal loss remains controversial (483 132). It is therefore expected status epilepticus and chronic temporal lobe epilepsy have different effects on hippocampal dentate granule cell GABA, receptors.
Epilepsia
In kindling, subconvulsive electrical stimulation applied repeatedly to various regions of the brain evokes progressively prolonged behavioral and EEG seizures that terminate in generalized tonic-clonic seizures. However, there are important differences between the gradual plasticity occurring during the kindling process and the rapidly evolving changes of status epilepticus reported here. Several studies have reported enhanced [3H]-muscimol and [3H]-benzodiazepine binding in hippocampal membranes (53) and specifically in the hippocampal dentate gyrus (5435). This increase in the hippocampal dentate granule cell GABAA receptors after kindling was associated with an increase in the amplitude of miniature inhibitory postsynaptic currents and enhancement of paired pulse depression of the kindled dentate gyrus (56) . These long-term changes in GABA, receptor-mediated inhibition in the dentate gyrus were likely to be antiepileptic in nature. The findings of this study, however, do not contradict studies on the kindling model. Although inhibitory neurotransmission in the dentate gyrus was enhanced during kindling and diminished during status epilepticus, the changes in kindling were slower to develop compared with the rapid changes that occur during status epilepticus.
In electrical stimulation models of epilepsy, GAB A, receptor-mediated inhibition in the dentate gyrus was chronically reduced, but this reduction was hypothesized to be due to circuit rearrangement and dormancy of basket cells (39 changes that were observed in these studies were acute, occurring over minutes, whereas previous reports documented changes that were chronic, occurring over several weeks. Finally, previous studies reported increased Zn++ sensitivity of hippocampal dentate granule cell GABA, receptors, whereas the current study reports diminished Zn+* sensitivity of granule cell GABA, receptors.
Possible molecular mechanisms for altered GABA, receptor function
This rapid, selective loss of benzodiazepine and Zn++ sensitivity is a novel form of GABA, receptor plasticity, and the underlying molecular basis is unclear. Diminished benzodiazepine sensitivity with development of benzodiazepine tolerance occurred over a prolonged period of time (59) . During development of cerebellar granule cells, benzodiazepine sensitivity of GABA, receptors is lost during maturation, in parallel with increasing expression of the a6-subtype in the GABA, receptor. Similarly, development of tolerance to benzodiazepines requires chronic benzodiazepine administration.
This selective loss of benzodiazepine and Zn++ sensitivity may result from altered structural composition or altered state of phosphorylation of GABAA receptors. Diazepam sensitivity of GABAA receptors requires the presence of the y2-subtype with a P-subtype and either a l -, 012-, a3-, or a5-subtype (13, 60) . Recombinant GABA, receptors expressed without the 72-subtype are highly sensitive to Znif (IC5,, < 10 kM, whereas GABA, receptors expressed with the y2-subtype were relatively insensitive to Zn++ (32, 33) . Therefore, one explanation for acute reduction of diazepam sensitivity of hippocampal dentate granule cell GAB A, receptors after seizures would be a loss of the y2-subtype from the receptor. However, this would not explain the diminished Zn++ sensitivity of these receptors. Another potential explanation for diminished diazepam and Zn++ sensitivity would be altered a-subtype expression, because a-subtypes are known to alter both Zn++ and diazepam sensitivity of the GABA, receptors. For example, recombinant GABA, receptors with 014-or 1x6-subtype with a P-subtype and a y2-subtype have low diazepam and Zn++ sensitivities (61) .
Seizures may alter GABA, receptor function by other mechanisms, such as posttranslational modification of GABA, receptors or release of endogenous benzodiazepine-like substances. Modification of GABA, receptors by phosphorylation is well demonstrated (60, 62, 63) , and seizures are known to modulate activities of CAMPdependent protein kinase, calcium-calmodulindependent protein kinase, and calcium-phospholipiddependent protein kinase (64, 65) . However, it remains to be shown that posttranslational modification can alter benzodiazepine and Zn++ sensitivity of GABA, receptors.
